AN ONCOLOGY drug has led to a 'drastic decrease' of HIV-infected cells in a French patient, raising the possibility the drug could help finally rid patients of the virus, according to a new study.
Published in the Annals of Oncology, the letter from Professor Jean-Philippe Spano, Parisian oncologist described the use of PD-1 inhibitor Nivolumab in an HIV patient - CLICK HERE for the study.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 17
